Results 11 to 20 of about 1,251,677 (333)

Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer. [PDF]

Oncol Lett, 2023
Kawaguchi R, Maehana T, Yamanaka S, Miyake R, Kawahara N, Iwai K, Yamada Y, Kimura F.   +7 more
europepmc   +3 more sources

Role of ADTRP (Androgen‐Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background The physiological function of ADTRP (androgen‐dependent tissue factor pathway inhibitor regulating protein) is unknown. We previously identified ADTRP as coregulating with and supporting the anticoagulant activity of tissue factor pathway ...
Maulin M. Patel, Amanda R. Behar, Robert Silasi, Girija Regmi, Christopher L. Sansam, Ravi S. Keshari, Florea Lupu, Cristina Lupu   +7 more
doaj   +2 more sources

Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study [PDF]

BMC Cancer
Background Endometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian cancer, as a
Mari Uomoto, Yukihide Ota, Yukio Suzuki, Asuna Yumori, Hiroto Narimatsu, Shiro Koizume, Shinya Sato, Yoshiyasu Nakamura, Shohei Myoba, Norihisa Ohtake, Haruya Saji, Etsuko Miyagi, Yohei Miyagi   +12 more
doaj   +2 more sources

Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix. [PDF]

Oncol Rep, 2021
Ota Y, Koizume S, Nakamura Y, Yoshihara M, Takahashi T, Sato S, Myoba S, Ohtake N, Kato H, Yokose T, Miyagi E, Miyagi Y.   +11 more
europepmc   +3 more sources

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes. [PDF]

Blood Vessel Thromb Hemost
Eustes AS, Palani Kumar MK, Peterson JA, Mast AE, Lentz SR, Dayal S.   +5 more
europepmc   +2 more sources

Tissue factor pathway inhibitor and bleeding tendency: can hormonal state explain the differences? [PDF]

Blood Adv, 2021
Dahm AEA, Sandset PM.
europepmc   +3 more sources

Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation. [PDF]

Curr Opin Hematol
Ahnström J, Petri A, Crawley JTB.
europepmc   +2 more sources

Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein [PDF]

Journal of Thrombosis and Haemostasis, 2013
Emily K. Waters, Ryan M. Genga, Heather A. Thomson, Jeffrey C. Kurz, Robert G. Schaub, F. Scheiflinger, Kathleen E. McGinness   +6 more
openalex   +2 more sources

Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia. [PDF]

Haemophilia, 2019
Ellery PER, Hilden I, Thyregod P, Martinez ND, Maroney SA, Gill JC, Mast AE.   +6 more
europepmc   +3 more sources

Investigating tissue factor pathway inhibitor and other protease and protease inhibitors and their association with major adverse aortic events in patients with abdominal aortic aneurysm. [PDF]

Res Pract Thromb Haemost
Khan H, Zamzam A, Shaikh F, Saposnik G, Mamdani M, Qadura M.   +5 more
europepmc   +2 more sources